Skip to main content
. Author manuscript; available in PMC: 2019 Jul 22.
Published in final edited form as: Curr Opin HIV AIDS. 2019 Jul;14(4):309–317. doi: 10.1097/COH.0000000000000551

Figure. 2.

Figure. 2.

Luminex reactivity of V2p mAb 8490 (A) and V2i mAb 697–30D (B) vs. cyclic V2 peptide (column 1), V1V2-tags (columns 2–4), V1V2-gp70 fusion proteins (columns 5–8), C5 peptide (column 9) and BSA (column 10). The negative control is shown at right.